Stock ATNM ACTINIUM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Actinium Pharmaceuticals, Inc.

Equities

ATNM

US00507W2061

Market Closed - Nyse
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
8.15 USD +0.49% Intraday chart for Actinium Pharmaceuticals, Inc. -4.12% +60.43%
May. 20 Transcript : Actinium Pharmaceuticals, Inc. - Special Call
May. 15 Actinium Announces Oral Presentation Detailing Improved Survival Outcomes in Tp53 Positive Patients At the Eha 2024 Annual Congress and Presentation of Long-Term Efficacy Results in Older Patients Receiving an Iomab-B Led Bone Marrow Transplant in the Phase 3 Sierra Trial CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ATNM Stock
  4. Revisions Actinium Pharmaceuticals, Inc.